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Background: Although excitation-contraction (EC) coupling in skeletal muscle relies on physical activation of the
skeletal ryanodine receptor (RyR1) Ca2+ release channel by dihydropyridine receptors (DHPRs), the activation pathway
between the DHPR and RyR1 remains unknown. However, the pathway includes the DHPR β1a subunit which is
integral to EC coupling and activates RyR1. In this manuscript, we explore the isoform specificity of β1a activation of
RyRs and the β1a binding site on RyR1.
Methods: We used lipid bilayers to measure single channel currents and whole cell patch clamp to measure L-type
Ca2+ currents and Ca2+ transients in myotubes.
Results: We demonstrate that both skeletal RyR1 and cardiac RyR2 channels in phospholipid bilayers are activated by
10–100 nM of the β1a subunit. Activation of RyR2 by 10 nM β1a was less than that of RyR1, suggesting a reduced affinity of
RyR2 for β1a. A reduction in activation was also observed when 10 nM β1a was added to the alternatively spliced (ASI(−))
isoform of RyR1, which lacks ASI residues (A3481-Q3485). It is notable that the equivalent region of RyR2 also lacks four of
five ASI residues, suggesting that the absence of these residues may contribute to the reduced 10 nM β1a activation
observed for both RyR2 and ASI(−)RyR1 compared to ASI(+)RyR1. We also investigated the influence of a polybasic motif
(PBM) of RyR1 (K3495KKRRDGR3502) that is located immediately downstream from the ASI residues and has been
implicated in EC coupling. We confirmed that neutralizing the basic residues in the PBM (RyR1 K-Q) results in an ~50 %
reduction in Ca2+ transient amplitude following expression in RyR1-null (dyspedic) myotubes and that the PBM is also
required for β1a subunit activation of RyR1 channels in lipid bilayers. These results suggest that the removal of β1a subunit
interaction with the PBM in RyR1 could contribute directly to ~50 % of the Ca2+ release generated during skeletal EC
coupling.
Conclusions: We conclude that the β1a subunit likely binds to a region that is largely conserved in RyR1 and RyR2 and that
this region is influenced by the presence of the ASI residues and the PBM in RyR1.
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Contraction in skeletal and cardiac muscle depends on Ca2
+ release from the intracellular sarcoplasmic reticulum (SR)
Ca2+ store through ryanodine receptor (RyR) Ca2+ release
channels embedded in the SR membrane. This Ca2+ release
is crucial to excitation-contraction (EC) coupling. During
EC coupling, cardiac RyRs (RyR2) are activated by an influx
of extracellular Ca2+ through depolarization-activated dihy-
dropyridine receptor (DHPR) L-type channels located in
the surface and transverse-tubule membranes. In contrast,
EC coupling in skeletal muscle is independent of extracellu-
lar Ca2+, apparently requiring a physical interaction be-
tween skeletal isoforms of the RyR (RyR1) and DHPR [1, 2].
However, despite exhaustive investigation, the physical
components of this interaction still remain unclear [3, 4]
and are investigated in this manuscript.
It is well established that the skeletal isoforms of both the
membrane spanning α1S subunit and the cytoplasmic β1a
subunit of the DHPR heteropentamer are essential for skel-
etal EC coupling [5, 6]. The α1S subunit contains the volt-
age sensor for EC coupling [7, 8] and the “critical” region
for skeletal EC coupling (residues L720-764/5) in its intra-
cellular II-III loop [9–11]. The β1a subunit is responsible
for the targeting of the DHPR to the triad and assembly
into tetrads that are closely aligned with RyR1 in the SR
[12–14]. There is also evidence that the β1a subunit also
plays an active role in the EC coupling process. The β1a
subunit directly activates RyR1 channels incorporated into
lipid bilayers and enhances voltage-activated Ca2+ release
in skeletal muscle fibers [5, 15, 16]. The C-terminal region
of β1a (V490-M524) supports β1a binding to RyR1 in vitro
and influences voltage-induced Ca2+ release in mouse
myotubes [15, 17, 18]. A peptide corresponding to the
same residues mimics full length β1a subunit activation of
RyR1 channels in lipid bilayers [15] and a truncated pep-
tide of the same region enhances voltage-induced Ca2+ re-
lease to the same degree as the full length β1a subunit in
intact adult mouse muscle fibers [16, 19]. Furthermore,
overexpression of a β subunit interacting protein, Rem, in
adult mouse skeletal muscle fibers was recently shown to
reduce voltage-induced Ca2+ transients by ~65 % without
substantially altering α1S subunit membrane targeting or
intramembrane gating charge movement or SR Ca2+ store
content [20]. This suggests that the DHPR-RyR1 interaction
may be uncoupled by virtue of direct interference of β1a
subunit. Residues in RyR1 that influence binding to the β1a
subunit have also been identified. The M3201-W3661 frag-
ment of RyR1 binds to β1a and the strength of binding is
substantially reduced by replacing the six basic residues in a
polybasic motif (PBM; K3495KKRRDGR3502) with gluta-
mines [18]. Replacement of the same six residues with glu-
tamines in the full-length RyR protein substantially reduces
depolarization-dependent Ca2+ release [18]. The in vitro
studies indicate a high-affinity interaction between theisolated RyR1 and the β1a subunit that is influenced by the
PBM. However, the basic residues unlikely bind directly to
the hydrophobic residues in the β1a C-terminus, although
they could contribute to the overall conformation of the
binding domain [21]. Similarly, it is unlikely that basic
residue binding to the hydrophobic residues could contri-
bute to EC coupling, although both basic residues and
hydrophobic residues in the β1a C-terminus influence EC
coupling [16, 19].
The fact that skeletal DHPR and RyR isoforms are critical
for skeletal-type EC coupling [22–26] suggests that
isoform-specific regions of these proteins enable unique in-
teractions in skeletal muscle. Also, in the context of iso-
form dependence, we reported that an alternatively
spliced region of RyR1 (A3481-Q3485), located close to
the PBM, is significant in setting the gain of EC coupling
[27]. It is notable that RyR2 lacks the equivalent sequence
to the ASI residues in ASI(+)RyR1 and, in this respect,
more closely resembles the ASI(−)RyR1 isoform. There-
fore, here we examined the RyR isoform dependence of
the in vitro interaction with the β1a subunit. We use the
RyR isoforms as tools to explore regions of the RyR1 that
influence its interaction with the C-tail of the β1a subunit.
Interactions between RyR2 and the cardiac β subunit
were not examined as they have no physiological sig-
nificance, and there is little sequence homology be-
tween the C-terminal tails of the cardiac and skeletal
β isoforms [12–14].
The results indicate that while β1a activates RyR1 and
RyR2 isolated from the skeletal muscle and the heart and
activates recombinant ASI(−)RyR1 and ASI(+)RyR1, β1a
activation of RyR2 and AS1(−)RyR1 requires higher β1a
concentrations than that required to activate RyR1 or
ASI(+)RyR1. In addition, we show that neutralization of the
basic residues in the RyR1 PBM abolishes β1a activation of
RyR1 in lipid bilayers and confirm that this also markedly
reduces voltage-dependent Ca2+ release in skeletal myo-
tubes. Together, the results reinforce the conclusion that
β1a binding to RyR1 contributes to EC coupling and suggest
that the region encompassing the adjacent ASI residues
and PBM is a determinant of β1a binding to and regulation
of RyR1.
Methods
The work was approved by The Australian National
University Animal Experimentation Ethics Committee
(Australian Capital Territory, Australia) and by the
University Committee on Animal Resources at the
University of Rochester (New York, USA).
Preparation of RyR1 ASI (−) and K-Q cDNA
The ASI(−)RyR1 variant was introduced into rabbit RyR1
cDNA (accession #X15750) using two-step site-directed
mutagenesis as described previously [28]. The K-Q mutant
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rabbit RyR1 cDNA by two-step site-directed mutagenesis
in the following manner: using a BsiWI/BamHI subclone
of RyR1, residues R3498Q and R3499Q were introduced
via mutagenesis to create a double mutation (R3498Q/
R3499Q). This mutant was used as a template to intro-
duce a third mutation R3502Q. Finally, glutamine substi-
tutions for residues K3495, K3496, and K3497 were
introduced into the triple mutated plasmid to generate the
PBM mutant Q3495QQQQGDQ3502 (K-Q mutant). The
entire PCR-modified cDNA portion of the BswiWI/
BamHI mutant subclone was confirmed by sequence ana-
lysis and then cloned back into full-length RyR1.
Preparation of SR vesicles
Skeletal muscle SR vesicles were prepared from back
and leg muscles (fast twitch skeletal muscle) from New
Zealand white rabbits [29–31] and cardiac SR vesicles
collected from sheep hearts [32, 33]. Vesicles were
stored at −70 °C.
Transfection and preparation of microsomal protein
Microsomal vesicles were collected from HEK293 trans-
fected with recombinant rabbit RyR1 ASI(+), ASI(−), or
K-Q RyR1 mutant cDNAs in mammalian expression
vector (pCIneo) as described previously [28] with minor
modifications. HEK cells were grown in 175-mm2 flasks
at 37 °C, 5 % CO2 in 10 % fetal calf serum in MEM. At
50–60 % confluence, cells were transfected with 80 μg
cDNA in a phosphate buffer solution (125 mM CaCl2,
70 mM NaH2PO4, 140 mM NaCl, 76 mM HEPES,
7 mM Na2HPO4, pH 7.2) using a calcium phosphate
precipitation method. Cells were maintained for 48 h
and then harvested in phosphate buffer (137 mM NaCl;
7 mM Na2HPO4; 2.5 mM NaH2PO4.H2O; and, 2 mM
EGTA, pH 7.4). The pellet was resuspended in homogen-
izing buffer (300 mM sucrose, 5 mM imidazole, 1×
complete EDTA-free protease inhibitor cocktail, pH 7.4),
homogenized and centrifuged at 11,600 × g for 20 min.
The resulting pellet was resuspended in homogenizing
buffer, further homogenized and centrifuged at 91,943 × g
for 2 h. The pellet was resuspended in homogenizing buf-
fer, homogenized, and then briefly sonicated. The micro-
somal mixture was separated into 15 μL aliquots and
stored at −70 °C.
Preparation and injection of dyspedic myotubes
Primary cultures of myotubes were obtained from skeletal
myoblasts isolated from newborn RyR1-null (dyspedic)
mice as previously described [34, 35]. Four to 6 days after
initial plating of myoblasts, nuclei of dyspedic myotubes
were microinjected with cDNAs encoding CD8 (0.1 μg/μl)
and the appropriate RyR1 expression plasmid (0.5 μg/μl)
[36]. Expressing myotubes were identified 2–4 days aftercDNA microinjection by incubation with CD8 antibody
beads (Dynabeads, Dynal USA). All animals were housed
in a pathogen-free area at the University of Rochester and
experiments performed in accordance with procedures
reviewed and approved by the local University Commit-
tees on Animal Resources.
Preparation of β1a subunit
The β1a protein was expressed in transformed Escheri-
chia coli BL21(DE3) and purified as described previously
[15]. The proteins were dialyzed against a phosphate
buffer (50 mM Na3PO4, 300 mM NaCl, pH 8) and
stored at −70 °C.
Single-channel recording and analysis
Channels from cardiac, skeletal, or HEK293 microsomal
vesicles were incorporated into lipid bilayers with solu-
tions containing (mM): cis (20 CsCl, 230 CsCH3O3S, 10
TES, and 1 CaCl2) and trans (20 CsCl, 30 CsCH3O3S,
10 mM TES, and 1 CaCl2), pH 7.2. After RyR incorpor-
ation, 200 mM CsMS was added to the trans solution
for symmetrical [Cs+]. BAPTA was added to the cis solu-
tion as determined with a Ca2+ electrode to achieve
10 μM Ca2+, and 2 mM ATP was added. Bilayer poten-
tial, Vcis-Vtrans, was switched between −40 and +40 mV.
Channel activity under each condition was analyzed over
180 s using the program Channel 2 (developed by P. W.
Gage and M. Smith). Threshold levels for channel open-
ing were set to exclude baseline noise at ~20 % of the
maximum single-channel conductance and open prob-
ability (Po), mean open time (To), and closed open time
(Tc) measured. Dwell-time distributions for each channel
were obtained using the log-bin method [37–39]. Event
frequency (probability) was plotted against equally
spaced bins (on a logarithmic scale) for open or closed
durations (seven bins per decade). The time constants are
indicated by the frequency peaks. The area under each
peak indicates the fraction of single-channel open or
closed events falling into each time constant component.
Simultaneous measurements of macroscopic Ca2+
currents and transients in myotubes
The whole-cell patch clamp technique was used to simul-
taneously measure voltage-gated L-type Ca2+ currents (L
currents) and Ca2+ transients in expressing myotubes [36].
Patch clamp experiments were conducted using an exter-
nal solution consisting of (in millimolar): 145 TEA-Cl, 10
CaCl2, and 10 HEPES, pH 7.4 with TEA-OH and an in-
ternal pipette solution consisting of (in millimolar): 145
Cs-aspartate, 10 CsCl, 0.1 Cs2-EGTA, 1.2 MgCl2, 5 Mg-
ATP, 0.2 K5-fluo-4, and 10 HEPES, pH 7.4 with CsOH.
Peak L-current magnitude was normalized to cell capaci-
tance (pA/pF), plotted as a function of the membrane po-
tential (I-V curves in Fig. 6c), and fitted according to:
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where Gmax is the maximal L-channel conductance, Vm
is test potential, Vrev is the L-channel reversal potential,
VG1/2 is the potential for half-maximal activation of
Gmax, and kG is a slope factor. Relative changes in fluo-4
fluorescence (ΔF/F) were measured at the end of each
200-ms depolarization, plotted as a function of the
membrane potential, and fitted according to:
ΔF=F ¼ ΔF = Fmaxð Þ= 1 þ exp V F1=2−Vm
 
= kF
  
where ΔF/Fmax is the maximal fluorescence change,
VF1/2 is the potential for half-maximal activation of ΔF/
Fmax, and kF is a slope factor. The bell-shaped voltage
dependence of ΔF/F measurements obtained in RyR1 K-
Q mutant-expressing myotubes were fitted according to
the following equation:
ΔF=F ¼ ΔF = Fð Þmax Vm− V revð Þ=k′ð Þ
 
= 1 þ exp V F1=2−Vm
 
= kF
  
where (ΔF/F)max, Vm, Vrev, VF1/2, and kF have their usual
meanings. The additional variable k′ is a scaling factor
that varies with (ΔF/F)max [40, 41]. The maximal rate of
voltage-gated SR Ca2+ release was approximated from
the peak of the first derivative of the fluo-4 fluorescence
trace (dF/dt) elicited during the test depolarization at
30 mV. Pooled current-voltage (I-V) and fluorescence-
voltage (ΔF/F-V) data in Table 1 are expressed as mean ±
SEM.
Immunofluorescence labeling
RyR-null (dyspedic) myotubes expressing either WT RyR
or RyR K-Q mutant that were plated on glass coverslips
were fixed and immunostained with a mouse monoclo-
nal anti-RyR antibody (34C, 1:10; Developmental Studies
Hybridoma Bank) and a sheep polyclonal anti-DHPR anti-
body (1:200; Upstate Biotechnology) overnight at 4 °C as
previously described [41]. On the following day, coverslips
were washed with PBS three times each for 5 min
and then incubated for 1 h at room temperature in
blocking buffer containing a 1:500 dilution of Alexa
Fluor 488–labeled donkey anti-mouse IgG (Molecular
Probes) and 1:500 dilution of rhodamine-labeledTable 1 Parameters of fitted I-V and [ΔF/F]-V curves
I-V data
Gmax (nS/nF) k (mV) Vhalf (mV)
WT RyR1 (n = 12) 264 ± 16 5.4 ± 0.4 10.5 ± 1.8
RyR1 K-Q (n = 10) 201 ± 17* 5.7 ± 0.3 11.5 ± 1.7
Maximal L-channel conductance (Gmax), the potential for half-maximal Gmax (Vhalf), s
for I-V data presented in Fig. 6c. Maximal Ca2+ transient [(ΔF/F)max], the potential at
mean ± SE for [ΔF/F]-V data presented in Fig. 6d
*p < 0.05 vs WT RyR1-expressing dyspedic myotubesdonkey anti-sheep IgG (Jackson ImmunoResearch La-
boratories Inc.) and washed with PBS (three times for
5 min each). Coverslips were mounted on glass slides
and images obtained using a Nikon Eclipse-C1 con-
focal microscope (Nikon Instruments Inc.) and a 40×
oil objective. All confocal images were sampled at a
spatial resolution (pixel diameter) of 100 nm.
Statistics
Average data are given as the mean ± SEM. Statistical
significance was evaluated by a paired or unpaired two-
way Student’s t-test or analysis of variance (ANOVA)
with Fisher’s post hoc test, as appropriate. The numbers
of observations (N) are given in the figure legends. To
reduce the effects of variability in control single-channel
activity parameters (PoC, TcC, ToC) and to evaluate pa-
rameters after β1a subunit (PoB, TcB, ToB) addition, data
were expressed as the difference between the logarithmic
values, i.e., log10 rel Po = log10PoB–log10PoC. The differ-
ence from control was assessed with a paired t-test
applied to log10PoC and log10PoB. Variance in Po par-
ameter values was assessed with an unpaired t-test. A
p value of <0.05 was considered significant.
Results
Ability of the β1a subunit to activate different RyR
isoforms
The β1a subunit activates RyR1 and RyR2 channels
As we reported previously [15], when added to the cyto-
plasmic cis chamber, the full-length β1a subunit increases
the activity of native RyR1 channels incorporated into
planar lipid bilayers (Fig. 1a). Both 10- or 100-nM
concentrations of β1a subunit maximally activate RyR1
channels in the presence of 10 μM Ca2+ and 2 mM
Na2 ATP [15]. The records in Fig. 1b show that RyR2
channel activity also increases upon cytoplasmic ex-
posure to 10 nM β1a subunit, but in contrast to
RyR1, greater activation of RyR2 is observed with
100 nM β1a. On average, addition of 10 nM or
100 nM β1a to the cis solution significantly increased
the relative Po of RyR2 by 1.8-fold and 2.6-fold, re-
spectively (Fig. 2a, left). Data is presented as average
relative Po which is the average of the logarithm to
the base 10 of Po of each individual channel in the[ΔF/F]-V data
Vrev (mV) (ΔF/F)max k (mV) Vhalf (mV)
71 ± 1.8 3.4 ± 0.7 3.9 ± 0.5 -4.7 ± 1.6
70 ± 2.1 1.6 ± 0.3* 4.1 ± 04. -2.5 ± 1.7
lope factor (k), and reversal potential (Vrev). Values presented as mean ± SEM
half maximal fluorescence (Vhalf) and slope factor (k). Values presented as
10 pA
100 nM β1a Po = 0.196
1 s
Native RyR1
Control Po = 0.063
O
C
A
Control
100 nM β1a
Po = 0.055
Po = 0.09210 nM β1a
Po = 0.161
Native RyR2
O
C
B
Po = 0.17410 nM β1a
Fig. 1 β1a subunit increases RyR1 and RyR2 channel activity in lipid
bilayers. a and b Three second (3 s) traces of representative activity
from native (a) RyR1 or (b) RyR2 channels recorded at a test potential
of +40 mV. Openings are shown as upward inflections from the closed
(c) state to the maximum open (o) level. Results are shown before (top
panel; control, cis 10 μM [Ca2+] and 2 mM ATP) and after addition of
10 nM β1a subunit (middle panel) and then 100 nM β1a subunit
(bottom panel) to the cis chamber. Open probability (Po) is shown at
the right hand corner of each trace
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its internal control activity measured before applica-
tion of β1a. Use of relative Po eliminates any effect of
the normal variability between individual RyR chan-
nels [39, 42]. The logarithm is used to reveal the ex-
tent of variation of the effects of β1a. The average of
the Po parameter values are also shown to indicate
absolute level of each parameter (Fig. 2a–c, right),
however, the relative changes should be used as the
most accurate indicator of effects of β1a on RyRs. The
effects on RyR2 channel activity were similar at +40
and −40 mV (relative Po with 10 nM β1a increasing
by ~2-fold at +40 mV and ~1.7-fold at −40 mV), and
these values were combined in the average data in
Fig. 2a. It has been established that the activation of
RyR1 by β1a is maximal at 10 nM and does not in-
crease between 10 and 1000 nM [15]. Therefore, the
reduced efficacy of 10 nM β1a on RyR2 suggests that
affinity of RyR2 for β1a is lower than that of RyR1.The action of β1a on single-channel gating parameters
(Fig. 2b, c) reflected the changes in Po (Fig. 2a, left and
right). Both RyR1 and RyR2 activity increased with 10
and 100 nM β1a as a result of increases in mean channel
open time and an abbreviation of mean channel closed
time (Fig. 2b, c). There was also a trend towards a
greater increase in mean open time in RyR2 with the
higher β1a concentration that is consistent with the
greater RyR2 open probability in the presence of
100 nM β1a. In contrast, RyR1 mean open time was
similar at both β1a concentrations. Mean closed times
were similarly reduced for both RyR isoforms by 10 and
100 nM β1a.
The effects of β1a on the open (τo) and closed (τc) time
constant components and the relative distribution of
events between time constants is presented in Figs. 3
and 4. Open events in RyR1 and RyR2 channels were
well described by the sum of three time constants of ~1
(τo1), ~10 (τo2), and ~100 ms (τo3) (Fig. 3). Closed times
were also characterized by three time constants of ~1
(τc1), ~10 (τc2), and ~100 ms (τc3) (Fig. 3). Figure 4
shows plots of the average probability of open (Fig. 4a,
b, upper plots) and closed (Fig. 4a, b, lower plots) events
as a function of the average time constant in the absence
(control) and presence of either 10 or 100 nM β1a.
Neither the time constants nor the relative probability
of events for each time constant varied significantly
(p = 0.12–0.99) between +40 and −40 mV and thus
were combined in the average data.
Both 10 and 100 nM concentrations of β1a subunit
decreased the fraction of RyR2 openings in τo1 by
18.7 ± 1.8 % (p = 0.003) and 16.3 ± 2.0 % (p = 0.012),
respectively (Fig. 4b). There was a corresponding in-
crease in the fraction of events for the longer open
time constant components at both β1a concentrations
(Fig. 4b). In contrast to RyR2, the maximal increases
in RyR1 activity after exposure to 10 or 100 nM β1a
subunit were reflected in a reduction in the fraction
of RyR1 open events in τo1 and increases in events in
the longer time constant group (τo2) at both β1a con-
centrations (Fig. 4a). The closed time constant distri-
butions in RyR2 and RyR1 were also altered by both
10 and 100 nM β1a, albeit in slightly different ways.
There was an apparent transfer of 14.9 ± 3.1 % of
closed events in RyR2 from τc2 to τc1 with 10 nM β1a
and 13.8 ± 4.7 % with 100 nM β1a (Fig. 4b). In con-
trast, for RyR1, there were fewer long closed events
in τc3 and more short closed events in τc1 with both
10 and 100 nM β1a than in control (Fig. 4a).
Overall, the results indicate that 10 and 100 nM β1a
increase both RyR1 and RyR2 activity but with a reduced
activation of RyR2 by 10 nM β1a. The dwell-time distri-
butions indicate subtle differences between RyR1 and
RyR2 in the effects of β1a in redistribution between the
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Fig. 2 β1a subunit increases RyR1 and RyR2 channel activity in lipid bilayers. Single-channel gating parameters of RyR1 and RyR2 in response to
10 or 100 nM β1a subunit. a (left) Average relative Po (log10 rel Po) is the average of the differences between the logarithm of Po following addition
of β1a subunit (log10PoB) and the logarithm of the control Po (log10PoC), where PoC was measured before β1a subunit addition. b (left) Average relative
mean open time (log10 rel Tc). c (left) Average relative mean closed time (log10 rel To) were calculated in the same way as the average log10 rel Po
(above). a–c (right) The average single-channel parameter values are shown right of the corresponding relative values. a–c Single-channel parameters
were calculated from ~180 s of channel activity (at +40 and −40 mV). Data are shown for 0 nM β1a (black bar), 10 nM β1a subunit (dark shade bar), and
100 nM β1a subunit (light shade bar), when examined. Error bars indicate ± SEM., n = 7−15 experiments/bar. *p < 0.05 vs control determined using
paired (left) or un-paired (right) Student’s t-test, #p < 0.05 vs 10 nM β1a subunit with RyR2 determined by ANOVA
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duced a significant increase in events in the longest open
time constant component in RyR2 but not RyR1 activity,
while significantly reducing the number of events in the
longest closed time constant component of RyR1 but
not RyR2 activity.
The alternatively spliced ASI residues impact the functional
interaction between β1a and RyR1
There is a curious similarity between the cardiac RyR2 iso-
form and the ASI(−) splice variant of RyR1 in that both lackASI residues. This may be relevant to the effect of β1a on
RyR1 and its contribution to EC coupling as we have shown
that the presence of the alternatively spliced AS1 residues
influences the gain of EC coupling in skeletal myotubes
[27] and modulates RyR1 activity in vitro [28]. Therefore,
we determined the impact of the alternatively spliced ASI
residues on the activation of RyR1 by β1a. Recombinant
ASI(-)RyR1 and ASI(+)RyR1 constructs [28, 43] were incor-
porated into lipid bilayers and the actions of the β1a subunit
on channel activity examined (Fig. 5). The ASI(+) isoform
is the adult isoform of RyR1 and its sequence is equivalent
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the cloned wild type (WT) rabbit RyR1 sequence described
in the following section. It is notable in the single-channel ac-
tivity, as shown in Fig. 5a, b (and in Fig. 7 below), that the re-
combinant channels (both ASI(-)RyR1 and ASI(+)RyR1) display
strong sub-conductance (or sub-state) activity, with long channel
openings to levels at ~50 % of the maximal conductance.
Channel activity was measured as usual (“Methods”
section) with an open threshold set at ~20 % of the
maximum single-channel conductance to exclude base-
line noise but to include sub-conductance openings to
levels >20 % of the maximum. It is important to note
that similar amounts of sub-conductance activity were
seen in HEK293-expressed WT and ASI(−) comparedin Fig. 5 and in WT and RyR1 K-Q channels compared
in Fig. 8. Similarly, the smaller amounts of sub-
conductance activity were comparable in RyR1 and
RyR2 isolated from muscle tissue and compared in
Fig. 1. In each case, sub-state activity was similar in
constructs being compared.
Subconductance activity has been associated with full or
partial depletion of FKBP12 from RyRs [29, 30]. Densi-
tometry measurements of immunoprobed RyR and FKBP
following co-immunoprecipitation of the RyR1 complex
indicate a 65 % reduction (p = 0.014) in FKBP bound
to RyR1 in recombinant ASI(+) RyR1 when compared
to native RyR1 isolated from muscle. Thus, the sub-
conductance activity observed for the recombinant
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Fig. 4 Effects of β1a subunit on the distribution of RyR channel open and closed dwell times. The probability of open and closed events falling
into each time constant is plotted against the respective time constant. The open (τo, top graphs) and closed (τc, bottom graphs) time constants
and the probability of events in each time constant component were calculated from ~180 s of single channel activity (at +40 and −40 mV). Data
is shown for a RyR1 and b RyR2 before (open circle) and after addition of 10 nM β1a subunit (open triangle) or 100 nM β1a subunit (open
square), n = 6–12 channel traces. Error bars indicate ± SEM. The individual open time constants (τo1, τo2, and τo3) and individual closed time
constants (τc1, τc2, and τc3) are indicated on the top and bottom graphs, respectively. *p < 0.05 vs the probability of events in each time
constant in control with 10 nM β1a subunit, determined by ANOVA.
#p < 0.05 vs the probability of events in each time constant in
control with 100 nM β1a subunit, determined by ANOVA
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sion in HEK293 cells and reduced amounts associated
with the recombinant RyR1 channels.
Cytoplasmic addition of 10 nM β1a to ASI(+)RyR1
channels produced a significant ~4.4-fold increase in
relative Po and a significantly smaller ~2.3-fold increase
in relative Po of ASI(-)RyR1 (Fig. 5c). There was no sig-
nificant difference between the degree of activation of
the two RyR1 splice variants following application of
50 nM β1a (Fig. 5c), so that the efficacy of 10 nM β1a on
ASI(−)RyR1 isoform appears to be less than that on
ASI(+)RyR1. Therefore, the responses of both ASI(-)RyR1
and RyR2 that lack the ASI sequence to application of
10 nM β1a are significantly reduced compared with RyR
proteins that contain the ASI sequence, i.e., ASI(+)RyR1
or adult RyR1 isolated from rabbit skeletal muscle.
The impact of the polybasic K3495-R3502 residues on EC
coupling and β1a activation of RyR1
The RyR1 polybasic motif facilitates EC coupling in
expressing dyspedic myotubes
The PMB (residues K3495-R3502) in RyR1, located im-
mediately downstream from the ASI region (A3481-Q3485), has been implicated in β1a binding to RyR1 and
EC coupling [18]. To assess the effect of the PMB on the
interaction between β1a and RyR1 channels in bilayers, a
mutant of RyR1 in which all six polybasic residues were
substituted with glutamines (RyR1 K-Q) was con-
structed. The functional effects of the RyR1 K-Q mutant
on voltage-gated SR Ca2+ release and DHPR L-type cur-
rents were confirmed following expression in dyspedic
myotubes [18].
Depolarization-dependent Ca2+ release was measured
simultaneously with DHPR L-type Ca2+ currents
(Fig. 6a, b). Peak L-current density (Fig. 6c) and maximal
DHPR Ca2+ conductance (Gmax) were significantly reduced
in RyR1 K-Q mutant-expressing myotubes compared to
WT RyR1-expressing myotubes (Table 1). Consistent with
an earlier report [18], maximal voltage-induced SR Ca2+
release was also significantly reduced in RyR1 K-Q mutant-
expressing myotubes (Fig. 6d and Table 1). In addition, the
maximum rate of depolarization-induced Ca2+ release
(approximated from the peak of the first derivative of
the fluo-4 fluorescence trace elicited during a test
depolarization at 30 mV) was significantly reduced in
RyR1 K-Q-expressing myotubes compared to WT RyR1-
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Fig. 5 ASI residues enhance the effect of β1a on recombinant RyR1 channel activity in lipid bilayers. a, b Three second (3 s) traces of ASI(+)RyR1
(a) or ASI(−)RyR (b) activity at +40 mV, opening upwards from the closed (c) to maximum open (o) level, before (top panel; control, cis 10 μM
[Ca2+], no ATP) and after addition of 10 nM β1a subunit (middle panel) or 50 nM β1a subunit (bottom panel) to the cis chamber. c Average relative
Po (log10 rel Po) were calculated in the same ways as described for averaged relative Po in Fig. 2a, left. d Average Po. c and d Single channel
parameters were calculated from ~180 s of channel activity (at +40 and −40 mV). Data in d is shown for 0 nM β1a (black bar), 10 nM β1a subunit
(dark grey bar), and 50 nM β1a subunit (light grey bar). Error bars indicate + SEM, n = 9–12 experiments/bar. *p < 0.05 vs control or 0 nM β1a
subunit determined using paired (c) or un-paired (d) Student’s t-test, #p < 0.05 vs 10 nM β1a subunit on RyR1 ASI(+) determined by ANOVA
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the RyR1 K-Q mutation substantially reduces voltage-
induced SR Ca2+ release, with a small effect on max-
imal L-channel conductance. It should be noted that
the reduced Ca2+ release is unlikely to result from re-
duced expression of RyR1 K-Q as it was previously
shown that peak 4-chloro-m-cresol stimulated SRCa2+ release was similar in WT RyR1- and RyR1 K-
Q-expressing myotubes [18]. In addition, we found
that WT RyR1 and RyR1 K-Q exhibited a similar
punctate pattern and DHPR co-localization in ex-
pressing myotubes, consistent with similar levels of
WT and K-Q expression and junctional localization
(Additional file 1: Figure S1 and Additional file 2).
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count for the large reduction in voltage-induced SR
Ca2+ release observed in RyR1 K-Q-expressing myo-
tubes (Fig. 6d). This is supported by the sigmoidal
voltage dependence of peak Ca2+ release, a feature of
skeletal-type EC coupling demonstrating that Ca2+
release is independent of Ca2+ influx. The reduction
in depolarization-induced DHPR currents and SRCa2+ release could have resulted from poor targeting
of the RyR1 K-Q mutant to the triad junction. How-
ever, double immunofluorescence labeling of RyR1
and the DHPR α1 subunit in expressing myotubes
indicates that the DHPR and RyR1 proteins similarly
co-localized as indicated by the yellow puncta in the
overlays shown in Additional file 1. Therefore, com-
pared to WT RyR1, the efficacy of voltage-induced
Rebbeck et al. Skeletal Muscle  (2015) 5:23 Page 11 of 15SR Ca2+ release is reduced in RyR1 K-Q-expressing
myotubes.
The polybasic motif in RyR1 is required for β1a activation
of RyR1
We explored the possibility that the reduction in effi-
ciency of depolarization-induced Ca2+ release was due to
an effect of the K-Q substitution on gating properties of
the RyR channel or to its response to cytoplasmic [Ca2+]
or ATP. RyR1 K-Q mutant channels exhibited unitary
conductance of 222.3 ± 18.5 pS at +40 and 247.3 ± 33.1 pS
at −40 mV, similar (p = 0.07–0.78) to that of WT RyR1
(311.9 ± 25.2 pS at +40 and 236.5 ± 12.5 pS at −40 mV),
or ~220 pS as previously reported for WT RyR1 expressed
in HEK293 cells under the recording conditions used in
this study [44].
The effects of cytoplasmic Ca2+ and ATP were similar
(p = 0.356–0.894) between +40 and -40 mV, and the data
were combined. A decrease in cis free [Ca2+] from 1 mM
to 10 μM caused a 1.7-fold increase in WT RyR1 Po and a
similar 1.6-fold increase in RyR1 K-Q Po, (log10 rel Po of
0.22 ± 0.06 [p = 0.013] and 0.20 ± 0.09 [p = 0.048], respect-
ively, n = 7 for each). Similar increases in Po with a de-
crease in cis free [Ca2+] from 1 mM to 10 μM have been
reported previously for recombinant WT RyR1 channels
in lipid bilayers [44] and for [3H]ryanodine binding to
RyR1 [33]. Addition of 2 mM Na2 ATP to the cis solution
increased WT RyR1 activity by 2.2-fold and RyR1 K-Q ac-
tivity by 2.5-fold (log10 rel Po of 0.34 ± 0.12 [p = 0.032] and
0.40 ± 0.14 [p = 0.037], respectively, n = 7 for each). As ob-
served for recombinant WT RyR1, prominent sub-stateB
100 nM β1a
RyR1 K-Q
Control
A WT RyR1
Control
100 nM β1a
Fig. 7 The K-Q mutation abolishes β1a activation of RyR1 activity. a, b Thre
at +40 mV, opening upward from the closed (c) state to the maximum ope
and after addition of 100 nM β1a subunit (bottom panel) to the cis chambeactivity was also observed for recombinant RyR1 K-Q
channels (Fig. 7a, b). The similar conductance, sub-state
activity, and regulation by Ca2+ and ATP between WT
RyR1 and RyR1 K-Q channels indicate that the K-Q muta-
tion does not markedly alter RyR1 function in the absence
of the β1a subunit.
As before (Figs. 1, 2, 3, 4 and 5), cis addition of
100 nM β1a significantly increased WT RyR1 channel ac-
tivity (Fig. 7a). In marked contrast, the activity of RyR1
K-Q channels was unaffected by addition of 100 nM
β1a (Fig. 7a). As effects of the β1a subunit on WT or
RyR1 K-Q channels did not differ (p = 0.677–0.991) be-
tween +40 and −40 mV, values at these two potentials
were again combined in the average data. On average,
addition of 10 or 100 nM β1a significantly increased WT
RyR1 relative Po by 1.8- and 1.9-fold, respectively
(Fig. 8a), due to a significant increase in mean open time
(Fig. 8b) and decrease in mean closed time (Fig. 8c). On
the other hand, neither the relative Po nor the mean
open or closed times of RyR1 K-Q channels were signifi-
cantly altered by addition of either 10 or 100 nM β1a
subunit (Fig. 8a–c). Thus, the ability of the β1a subunit
to activate RyR1 was abolished by neutralizing the poly-
basic residues within the K4395-R3502 region, indicating
that the PBM is required for the functional effect of β1a
subunit on RyR1 activity.
Discussion
The results presented here provide novel insight into
the regions of RyR1 that influence the action of the β1a
subunit on RyR1 activity and have implications for theO
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Our results demonstrate that the functional effect of
100 nM β1a subunit is conserved between RyR1 and
RyR2, although the activation by 10 nM β1a was lower
in RyR2 than in RyR1. Interestingly, a difference was
also observed for the activation of ASI(−)RyR1 and
ASI(+)RyR1 isoforms by 10 nM β1a, in that the lower
concentration of β1a was also less effective in activating
ASI(−)RyR1 than ASI(+)RyR1. In contrast to the
maintained, although different, activation of the two RyR
isoforms by the β1a subunit, neutralization of the PBM in
RyR1 abolished β1a activation of RyR1. One interpretation
of this finding is that the ~50 % reduction in
depolarization-dependent Ca2+ release results from
disruption of direct β1a activation of RyR1 during EC
coupling.The action of β1a subunit on RyR1 and RyR2 channel
activity is largely conserved
The activation of RyR1 and RyR2 by β1a suggests that
the β1a binding site is conserved across these RyR iso-
forms. The small concentration-dependent differences
between effects on RyR1 and RyR2 suggest minor differ-
ences in either the binding residues or the binding
pocket that reduces the affinity of β1a for RyR2 (and
ASI(−)RyR1). It is difficult to identify specific sequences
that could account for the different affinities for β1a as
there is a 13.2 % (>600 residues) sequence disparity be-
tween RyR1 and RyR2 isoforms, according to a CLUS-
TALW multiple alignment [45] of rabbit RyR1 [Swiss-
Prot: P11716.1] and rabbit RyR2 [Swiss-Prot: P30957.3].
Given that the string of positive residues is reduced from
six to five, this variation is unlikely to account for the
Rebbeck et al. Skeletal Muscle  (2015) 5:23 Page 13 of 15observed concentration-dependent difference between
β1a modulation of the two isoforms, although such a
possibility cannot be fully excluded. Interestingly, except
for one additional positive charge in the RyR1, the PBM
is conserved in RyR2 (RyR1: K3495KKRR_ _ R3502 and
RyR2: K3452MKRK_ _R3459) and thus is unlikely to
account for the observed concentration-dependent dif-
ference between β1a modulation of the two isoforms.
However, just upstream from the PBM, four of the five
ASI residues in RyR1 (A3481-Q3485) are missing from
the rabbit (and predicted pig) RyR2 sequence. It may be
significant that the lack of ASI residues in full-length
ASI(−)RyR1 reduces the efficacy of 10 nM β1a-mediated
activation. Thus, it is plausible that the difference be-
tween β1a modulation of RyR1 and RyR2 is partially due
to the presence or absence of the ASI residues, respect-
ively. The conservation of the modulatory effect of β1a
on RyR1 and RyR2 does not reflect the in vivo studies
showing that RyR2 is unable to replace RyR1 in skeletal
muscle EC coupling [25, 46]. However, the lack of skel-
etal muscle EC coupling in RyR2-expressing dyspedic
myotubes is most likely due to the fact that DHPR
tetrads are not restored in RyR2-expressing dyspedic
myotubes [46], indicating that β1a is unable to correctly
align DHPRs with RyR2 in order to ensure a direct inter-
action between the two proteins. It is also possible that
the II-III loop critical region is unable to engage with
RyR2 through β1a.
The importance of the RyR1 polybasic motif for β1a subunit
increase in RyR1 channel activity
The role of the RyR1 PBM in the β1a-mediated increase
in channel activity was assessed from the response of re-
combinant RyR1 K-Q channels in bilayers to the
addition of the β1a subunit. RyR1 K-Q and WT RyR1
channel conductance and regulation by cytoplasmic
modulators were similar, indicating that RyR1 K-Q chan-
nels function normally. However, RyR1 K-Q channel ac-
tivity was unaltered by the β1a subunit. Therefore, the
reduction in voltage-gated Ca2+ release observed in
RyR1 K-Q-expressing myotubes is likely to reflect a spe-
cific effect of the polybasic residues on β1a subunit regu-
lation of RyR1 channel activity during EC coupling
rather than a general effect on RyR1 channel function.
However, we cannot rule out the possibility that modest
differences in RyR1 expression contribute to the reduced
L-channel conductance and voltage-gated Ca2+ release
in K-Q-expressing myotubes, although this seems un-
likely given previous reports of 4-chloro-m-cresol stimu-
lated SR Ca2+ release in myotubes RyR1 K-Q [18] and
the data in Additional file 1.
Given that the PBM in the larger M3201-W3661 frag-
ment of RyR1 is required for pull down of the β1a sub-
unit [18], it is likely that the lack of an effect of β1a onRyR1 K-Q channels is due to the inability of β1a to bind
to the PBM mutant channel. Alternatively, the PBM may
be important for maintaining RyR1 in a conformation
permissive for β1a binding, rather than directly contrib-
uting to binding, as the RyR1 basic residues would be
unlikely to interact with the hydrophobic residues in the
β1a C-terminal domain (L496, L500, and W503) previ-
ously shown to bind RyR1 [21]. In addition, although the
PBM is implicated in ASI-mediated inter-domain inhib-
ition of RyR1 [27, 43], the structure of this motif is not
altered by substituting three of the six basic residues
with alanine residues [27]. Thus, neutralization of the
PBM more likely disrupts the inter-domain interaction
rather than changes the intrinsic structure of the ASI-
polybasic region. In this case, disruption of the RyR1
PBM inter-domain interaction may alter an essential
conformation of the β1a binding site or prevent β1a ac-
cess to its binding site on RyR1.
The β1a subunit is unlikely to be the sole signaling
conduit between the DHPR and RyR1 during EC coup-
ling. Consistent with this, expression of the RyR1 K-Q
mutant in dyspedic myotubes partially restored sig-
moidal, depolarization-dependent Ca2+ release even
though β1a modulation of RyR1 in bilayers was abol-
ished. In addition, previous studies have also shown that
truncation of β1a C-terminal residues, essential for β1a
modulation of RyR1, also reduces but does not abolish
depolarization-induced Ca2+ release [17, 40], an outcome
that was also observed in adult skeletal muscle fibers
that overexpressed a β1a subunit interacting protein,
Rem [20]. Finally, alanine substitution of β1a subunit
hydrophobic triplet residues (L496, L500, and W503)
only partially reduces depolarization-induced Ca2+ release
in β1a null myotubes [14], despite this mutation fully abol-
ishing β1a modulation of RyR1 activity in vitro [21].
The role of the RyR1 ASI residues in β1a subunit increase in
RyR1 channel activity
It is curious that 10 nM β1a subunit increased
ASI(−)RyR1 activity less than ASI(+)RyR1 given that EC
coupling is enhanced in dyspedic myotubes that express
ASI(−)RyR1 relative to ASI(+)RyR1 [27]. The greater ac-
tivation of ASI(+)RyR1 by 10 nM β1a is consistent with
effects reported previously of agonists of RyR1, including
caffeine and 4-chloro-m-cresol [27, 28]. Thus, the in-
creased gain of EC coupling observed for ASI(-)RyR1
may not reflect a contribution of the β1a subunit to EC
coupling. However, it is possible that activation of RyR1
by agonist binding includes a common mechanism for
activation by agonists that differs from that involved in
EC coupling. As it is likely that more than one inter-
action between RyR1 and the DHPR is involved in EC
coupling, the combined result of these interactions may
produce different effects on the two alternatively spliced
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strongly by depolarization than ASI(+)RyR1 channels.
The possibility that the ASI region is involved in an in-
hibitory inter-domain interaction was previously investi-
gated using peptides corresponding to the ASI region
from T3471–G3500 [43]. The peptide corresponding to
the ASI(−) sequence was more effective in activating
ASI(-)RyR1 than ASI(+)RyR1. Together with the finding
that ASI(−)RyR1 channels were generally less active than
ASI(+)RyR1 channels, these findings suggest that stron-
ger inhibitory inter-domain interactions may exist in
ASI(−)RyR1. It is possible then that the triggering mech-
anism activated during EC coupling disrupts this inhibi-
tory inter-domain interaction giving rise to greater
activation of ASI(-)RyR1. This disruption may not occur
with RyR1 agonist binding and indeed a stronger inhibi-
tory inter-domain interaction in ASI(-)RyR1 may even
oppose activation by β1a and other agonists, allowing for
these triggers to more strongly activate ASI(+)RyR1
channels.
Conclusions
The results presented in this study suggest that a func-
tional β1a interaction is conserved between RyR1 and
RyR2 and that β1a activation of RyRs is regulated by the
presence of the ASI residues. Importantly, we also show
that the PBM residues are essential for direct activation
of RyR1 by β1a subunit in vitro. This suggests that
the ~50 % reduction in Ca2+ release during EC coupling
in dyspedic myotubes expressing RyR1 with a neutral-
ized PBM is due to removal of β1a activation of RyR1, and
hence, that other DHPR-RyR1 coupling elements (e.g., II-
III loop critical domain) contribute to transmission of the
remaining Ca2+ release during EC coupling.
Additional files
Additional file 1: Figure S1. Description of data: a figure with two
parts showing immune-fluorescent labeling of DHPR and RyR1 in
myotubes.
Additional file 2: A legend to additional Figure S1.
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